ArticleClinical transplantation2023

Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers.

Kevin A Reininger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.